Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Self-citationBaracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732
Self-citationCharacterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
Self-citationMaltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F., Gayan-Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,090
Self-citationPhysical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
Waschki, B., Kirsten, A., Holz, O., Müller, K.-C., Meyer, T., Watz, H., & Magnussen, H. (2011) · Chest · doi:10.1378/chest.10-2521 · Cited by 951
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Self-citationHalpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D.-C., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J., & Polkey, M. I. (2007) · Thorax · doi:10.1136/thx.2006.062026 · Cited by 728
“The endpoint measured was death or lung transplantation and median (range) follow up was 38 (1-54) months.”
BackgroundResultSkeletal muscle loss: cachexia, sarcopenia, and inactivity
Evans, W. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608a · Cited by 723
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Prado, C. M. M., & Heymsfield, S. B. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114550189 · Cited by 550
Cavaillès, A., Brinchault-Rabin, G., Dixmier, A., Goupil, F., Gut-Gobert, C., Marchand-Adam, S., Meurice, J.-C., Morel, H., Person-Tacnet, C., Leroyer, C., et al. (2013) · European Respiratory Review · doi:10.1183/09059180.00008612 · Cited by 510
Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation
Jones, S. E., Maddocks, M., Kon, S. S. C., Canavan, J. L., Nolan, C. M., Clark, A. L., Polkey, M. I., & Man, W. D.-C. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206440 · Cited by 435
Celli, B. R., Locantore, N., Yates, J., Tal-Singer, R., Miller, B. E., Bakke, P., Calverley, P., Coxson, H., Crim, C., Edwards, L. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1792oc · Cited by 432
Self-citationThe effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies
Poulain, M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051299 · Cited by 415
Biolo, G., Cederholm, T., & Muscaritoli, M. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.03.007 · Cited by 407
Nutritional assessment and therapy in COPD: a European Respiratory Society statement
Schols, A. M., Ferreira, I. M., Franssen, F. M., Gosker, H. R., Janssens, W., Muscaritoli, M., Pison, C., Rutten-van Mölken, M., Slinde, F., Steiner, M. C., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00070914 · Cited by 360
Self-citationQuadriceps wasting and physical inactivity in patients with COPD
Shrikrishna, D., Patel, M., Tanner, R. J., Seymour, J. M., Connolly, B. A., Puthucheary, Z. A., Walsh, S. L. F., Bloch, S. A., Sidhu, P. S., Hart, N., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00170111 · Cited by 331
“2 Skeletal muscle dysfunction is a well recognised extrapulmonary complication of chronic obstructive pulmonary disease (COPD) with loss of lean body mass identified as a key determinant of disability [1] and an independent predictor of mortality [2].”
BackgroundNutritional supplementation for stable chronic obstructive pulmonary disease
Ferreira, I. M., Brooks, D., White, J., & Goldstein, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000998.pub3 · Cited by 326
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314
Gosker, H. R., Zeegers, M. P., Wouters, E. F. M., & Schols, A. M. W. J. (2007) · Thorax · doi:10.1136/thx.2007.078980 · Cited by 303
Self-citationJaitovich, A., & Barreiro, E. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2140ci · Cited by 303
Obesity and the lung: 5 {middle dot} Obesity and COPD
Franssen, F. M. E., O'Donnell, D. E., Goossens, G. H., Blaak, E. E., & Schols, A. M. W. J. (2008) · Thorax · doi:10.1136/thx.2007.086827 · Cited by 302
Self-citationDecramer, M., Rennard, S., Troosters, T., Mapel, D. W., Giardino, N., Mannino, D., Wouters, E., Sethi, S., & Cooper, C. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 295
Self-citationCurrent status of research on osteoporosis in COPD: a systematic review
Graat-Verboom, L., Wouters, E. F. M., Smeenk, F. W. J. M., van den Borne, B. E. E. M., Lunde, R., & Spruit, M. A. (2009) · European Respiratory Journal · doi:10.1183/09031936.50130408 · Cited by 290
Self-citationPossible mechanisms underlying the development of cachexia in COPD
Wagner, P. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00074807 · Cited by 280
Cachexia: prevalence and impact in medicine
Tan, B. H., & Fearon, K. C. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328300ecc1 · Cited by 265
Agustí, A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-004fm · Cited by 265
Mortality in COPD: Causes, Risk Factors, and Prevention
Berry, C. E., & Wise, R. A. (2010) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510160 · Cited by 257
Body composition: Why, when and for who?
Thibault, R., Genton, L., & Pichard, C. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.011 · Cited by 251
McDonald, M.-L. N., Diaz, A. A., Ross, J. C., San Jose Estepar, R., Zhou, L., Regan, E. A., Eckbo, E., Muralidhar, N., Come, C. E., Cho, M. H., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201307-229oc · Cited by 250
Self-citationMuscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Doucet, M., Russell, A. P., Léger, B., Debigaré, R., Joanisse, D. R., Caron, M.-A., LeBlanc, P., & Maltais, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-704oc · Cited by 243
“This decision was justified given that a reduction in these two indices of muscle mass is a strong predictor of mortality in COPD (3, 47).”
Raiten, D. J., Ashour, F. A. S., Ross, A. C., Meydani, S. N., Dawson, H. D., Stephensen, C. B., Brabin, B. J., Suchdev, P. S., & van Ommen, B. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.194571 · Cited by 234
Tanimura, K., Sato, S., Fuseya, Y., Hasegawa, K., Uemasu, K., Sato, A., Oguma, T., Hirai, T., Mishima, M., & Muro, S. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-446oc · Cited by 221
Ribosome biogenesis: Emerging evidence for a central role in the regulation of skeletal muscle mass
Chaillou, T., Kirby, T. J., & McCarthy, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24604 · Cited by 211
Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women
Varraso, R., Fung, T. T., Barr, R. G., Hu, F. B., Willett, W., & Camargo, C. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.488 · Cited by 210
Hopkinson, N. S., Tennant, R. C., Dayer, M. J., Swallow, E. B., Hansel, T. T., Moxham, J., & Polkey, M. I. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-25 · Cited by 202
De Schutter, A., Lavie, C. J., & Milani, R. V. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.08.003 · Cited by 202
Wilkinson, D. J., Franchi, M. V., Brook, M. S., Narici, M. V., Williams, J. P., Mitchell, W. K., Szewczyk, N. J., Greenhaff, P. L., Atherton, P. J., & Smith, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00650.2013 · Cited by 195
The evaluation of body composition: A useful tool for clinical practice
Thibault, R., & Pichard, C. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000334879 · Cited by 193
Steuten, L. M. G., Creutzberg, E. C., Vrijhoef, H. J. M., & Wouters, E. F. (2006) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2005.09.001 · Cited by 184
Self-citationvan Wetering, C. R., Hoogendoorn, M., Mol, S. J. M., Rutten-van Molken, M. P. M. H., & Schols, A. M. (2010) · Thorax · doi:10.1136/thx.2009.118620 · Cited by 184
Self-citationThe mechanisms of cachexia underlying muscle dysfunction in COPD
Remels, A. H. V., Gosker, H. R., Langen, R. C. J., & Schols, A. M. W. J. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00790.2012 · Cited by 181
“In this review, we will refer to patients as underweight (low BMI only), muscle-atrophied (low FFMI and normal BMI), or cachectic (low FFMI and low BMI) based on reported body composition (90).”
BackgroundSelf-citationLainscak, M., von Haehling, S., Doehner, W., Sarc, I., Jeric, T., Ziherl, K., Kosnik, M., Anker, S. D., & Suskovic, S. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0023-9 · Cited by 179
Chan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 177
Cancer-Associated Cachexia and Underlying Biological Mechanisms
Baracos, V. E. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111151 · Cited by 177
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review
Cebron Lipovec, N., Beijers, R. J. H. C. G., van den Borst, B., Doehner, W., Lainscak, M., & Schols, A. M. W. J. (2016) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2016.1140732 · Cited by 177
Self-citationTriggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease
LANGEN, R. C. J., Gosker, H. R., Remels, A. H. V., & Schols, A. M. W. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.015 · Cited by 179
Self-citationWalter-Kroker, A., Kroker, A., Mattiucci-Guehlke, M., & Glaab, T. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-35 · Cited by 147
Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD
Vogiatzis, I., Simoes, D. C. M., Stratakos, G., Kourepini, E., Terzis, G., Manta, P., Athanasopoulos, D., Roussos, C., Wagner, P. D., & Zakynthinos, S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00112909 · Cited by 173
Myopenia—a new universal term for muscle wasting
Fearon, K., Evans, W. J., & Anker, S. D. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0025-7 · Cited by 173
Guo, Y., Zhang, T., Wang, Z., Yu, F., Xu, Q., Guo, W., Wu, C., & He, J. (2016) · Medicine · doi:10.1097/md.0000000000004225 · Cited by 170
ESPEN Guidelines on Enteral Nutrition: Cardiology and Pulmonology
Anker, S. D., John, M., Pedersen, P. U., Raguso, C., Cicoira, M., Dardai, E., Laviano, A., Ponikowski, P., Schols, A. M. W. J., Becker, H. F., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.017 · Cited by 170
Self-citationGea, J., Pascual-Guàrdia, S., Casadevall, C., Orozco‐Levi, M., & Barreiro, E. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.08.04 · Cited by 169
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A., Dalamaga, M., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 169
Body weight and mortality in COPD: focus on the obesity paradox
Spelta, F., Pasini, A. M. F., Cazzoletti, L., & Ferrari, M. (2017) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-017-0456-z · Cited by 169
Body Mass and Fat-Free Mass Indices in COPD
Ischaki, E., Papatheodorou, G., Gaki, E., Papa, I., Koulouris, N., & Loukides, S. (2007) · Chest · doi:10.1378/chest.06-2789 · Cited by 165
Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
Obesity, Physical Activity, and Mortality in a Prospective Chinese Elderly Cohort
Schooling, C. M., Lam, T. H., Li, Z. B., Ho, S. Y., Chan, W. M., Ho, K. S., Tham, M. K., Cowling, B. J., & Leung, G. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1498 · Cited by 154
Sanders, K. J. C., Kneppers, A. E. M., van de Bool, C., Langen, R. C. J., & Schols, A. M. W. J. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12062 · Cited by 148
Self-citationFalls in patients with chronic obstructive pulmonary disease: A call for further research
Roig, M., Eng, J. J., ROAD, J. D., & Reid, W. D. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.03.022 · Cited by 165
Farup, J., Madaro, L., Puri, P. L., & Mikkelsen, U. R. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.198 · Cited by 161
Lessons from ECLIPSE: a review of COPD biomarkers
Faner, R., Tal-Singer, R., Riley, J. H., Celli, B., Vestbo, J., MacNee, W., Bakke, P., Calverley, P. M. A., Coxson, H., Crim, C., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-204778 · Cited by 160
Self-citationHallin, R., Guðmundsson, G., Ulrik, C. S., Nieminen, M. M., Gíslason, Þ., Lindberg, E., Brøndum, E., Aine, T., Bakke, P. S., & Janson, C. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.04.009 · Cited by 160
Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy
Martí, S., Muñoz, X., Ríos, J., Morell, F., & Ferrer, J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00076405 · Cited by 159
Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?
Franssen, F. M. E., & Rochester, C. L. (2014) · European Respiratory Review · doi:10.1183/09059180.00007613 · Cited by 158
Sun, Y., Milne, S. B., Jaw, J. E., Yang, C., Xu, F., Li, X., Obeidat, M., & Sin, D. D. (2019) · Respiratory Research · doi:10.1186/s12931-019-1209-5 · Cited by 157
Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation
Janssen, D. J., Spruit, M. A., Leue, C., Gijsen, C., Hameleers, H., Schols, J. M., Wouters, E. F., & On behalf of the Ciro network (2010) · Chronic Respiratory Disease · doi:10.1177/1479972310369285 · Cited by 144
Self-citationFranssen, F. M. E., Rutten, E. P. A., Groenen, M. T. J., Vanfleteren, L. E. G. W., Wouters, E. F. �., & Spruit, M. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.03.012 · Cited by 156
Self-citationBenz, E., Wijnant, S. R. A., Trajanoska, K., Arinze, J. T., de Roos, E. W., de Ridder, M. A. J., Williams, R. D., van Rooij, F. J. A., Verhamme, K. M. C., Ikram, M. A., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00628-2021 · Cited by 155
Advances in understanding and assessing malnutrition
Soeters, P. B., & Schols, A. M. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832da243 · Cited by 119
Self-citationPhenotypes of Chronic Obstructive Pulmonary Disease
Friedlander, A. L., Lynch, D. A., Dyar, L. A., & Bowler, R. P. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701629663 · Cited by 152
Pulmonary Rehabilitation and Exercise Training in Chronic Obstructive Pulmonary Disease
Gloeckl, R., Schneeberger, T., Jarosch, I., & Kenn, K. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0117 · Cited by 148
Recent advances in the biology and therapy of muscle wasting
Glass, D., & Roubenoff, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05809.x · Cited by 128
Budweiser, S., Jörres, R. A., Riedl, T., Heinemann, F., Hitzl, A. P., Windisch, W., & Pfeifer, M. (2007) · CHEST Journal · doi:10.1378/chest.06-2124 · Cited by 146
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., & Maltais, F. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972307087205 · Cited by 145
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations
Vilaró, J., Ramírez-Sarmiento, A., Martínez‐Llorens, J., Mendoza, T., Álvarez, M. A. L., Sánchez-Cayado, N., Vega, Á., Gimeno, E., Coronell, C., Gea, J., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.05.001 · Cited by 145
Recommendations for epidemiological studies on COPD
Bakke, P. S., Rönmark, E., Eagan, T., Pistelli, F., Annesi‐Maesano, I., Maly, M., Meren, M., Vermeire, P. A., Vestbo, J., Viegi, G., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00193809 · Cited by 143
Telomere shortening in chronic obstructive pulmonary disease
Houben, J. M. J., Mercken, E. M., Ketelslegers, H. B., Bast, A., Wouters, E. F., Hageman, G. J., & Schols, A. M. W. J. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.003 · Cited by 141
Self-citationSarcopenia in COPD: relationship with COPD severity and prognosis
Costa, T. M. D. R. L., Costa, F. M., Moreira, C. A., Rabelo, L. M., Boguszewski, C. L., & Borba, V. Z. C. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000040 · Cited by 141
Pokharel, M. D., Flores, A. G., Marciano, D. P., Franco, M. C., Fineman, J. R., Aggarwal, S., Wang, T., & Black, S. M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103049 · Cited by 138
Graat‐Verboom, L., Spruit, M. A., van den Borne, B. E. E. M., Smeenk, F. W. J. M., Martens, E. J., Lunde, R., & Wouters, E. F. �. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.02.014 · Cited by 134
Self-citationBody composition and mortality after adult lung transplantation in the United States
Singer, J. P., Peterson, E. R., Snyder, M. E., Katz, P. P., Golden, J. A., D’Ovidio, F., Bacchetta, M., Sonett, J. R., Kukreja, J., Shah, L., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0973oc · Cited by 133
“Cachexia is prevalent in advanced chronic diseases, especially of the lung, and is independently associated with mortality (43, 44); sarcopenia is associated with mortality in transplant populations (45, 46).”
BackgroundChronic Endurance Exercise Induces Quadriceps Nitrosative Stress in Patients with Severe COPD
Barreiro, E., Rabinovich, R., Marin-Corral, J., Barbera, J. A., Gea, J., & Roca, J. (2008) · Thorax · doi:10.1136/thx.2008.105163 · Cited by 133
Joppa, P., Tkáčová, R., Franssen, F. M. E., Hanson, C., Rennard, S. I., Silverman, E. K., McDonald, M., Calverley, P. M. A., Tal‐Singer, R., Spruit, M. A., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.020 · Cited by 133
Self-citationSub-clinical left and right ventricular dysfunction in patients with COPD
Sabit, R., Bolton, C. E., Fraser, A. G., Edwards, J. M., Edwards, P. H., Ionescu, A., Cockcroft, J. R., & Shale, D. J. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.01.020 · Cited by 132
The COPD control panel: towards personalised medicine in COPD
Agustí, A. G. N., & MacNee, W. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202772 · Cited by 131
Nutrition in chronic obstructive pulmonary disease: A review
Rawal, G., & Yadav, S. (2015) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2015-0021 · Cited by 131
Managing malnutrition in COPD: A review
Keogh, E., & Williams, E. M. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106248 · Cited by 129
Favier, F. B., Costes, F., Defour, A., Bonnefoy, R., Lefai, E., Baugé, S., Peinnequin, A., Benoit, H., & Freyssenet, D. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00550.2009 · Cited by 127
Sin, D. D., & Man, S. F. P. (2005) · Thorax · doi:10.1136/thx.2005.044941 · Cited by 126
Stevenson, C. S., & Birrell, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.008 · Cited by 129
TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia?
Remels, A. H. V., Gosker, H. R., Schrauwen, P., Hommelberg, P. P. H., Sliwinski, P., Polkey, M., Galdiz, J., Wouters, E. F. M., Langen, R. C. J., & Schols, A. M. W. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-150714 · Cited by 122
Self-citationSzulc, P., Munoz, F., Marchand, F., Chapurlat, R. D., & Delmas, P. D. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28256 · Cited by 122
Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary Disease
Choudhury, G., Rabinovich, R., & MacNee, W. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.007 · Cited by 125
Iron deficiency as energetic insult to skeletal muscle in chronic diseases
Dzięgała, M., Josiak, K., Kasztura, M., Kobak, K. A., von Haehling, S., Banasiak, W., Anker, S. D., Ponikowski, P. P., & Jankowska, E. A. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12314 · Cited by 123
It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
McDonald, M., Wouters, E. F. �., Rutten, E. P. A., Casaburi, R. H., Rennard, S. I., Lomas, D. A., Bamman, M. M., Celli, B. R., Agustí, A. G. N., Tal‐Singer, R., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1073-3 · Cited by 119
Self-citationvan Venrooij, L. M. W., de Vos, R., Borgmeijer-Hoelen, M. M. M. J., Haaring, C., & de Mol, B. A. J. M. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1656 · Cited by 116
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.